ArticleArthritis research & therapy2016

B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.

Stefan Bruijnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.